Vanguard Capital Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding UTMD
MA
Vanguard Capital Management's UTMD Position: Q3 2026 in Review
Vanguard Capital Management increased its Utah Medical Products (UTMD) stake by 1.6% in Q3 2026, buying an estimated $158K and bringing the position to 136,753 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2748.
Vanguard Capital Management first reported a position in UTMD in Q1 2026 and has held it in 3 quarters since. 98 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.
- Vanguard Capital Management held 136,753 shares of Utah Medical Products worth $10.1M as of Q3 2026.
- Vanguard Capital Management bought 2,218 Utah Medical Products shares in Q3 2026, an estimated $158K.
- Utah Medical Products made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2748 holding.
- Vanguard Capital Management first reported a position in Utah Medical Products in Q1 2026 and has held it in 3 quarters since.
- 98 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.